SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-011448
Filing Date
2017-11-13
Accepted
2017-11-13 15:04:57
Documents
60
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fcsc-201793010qx3.htm 10-Q 961280
2 EXHIBIT 31 fcsc-2017930ex31.htm EX-31 9874
3 EXHIBIT 32 fcsc-20170930ex32.htm EX-32 6943
10 a10qgraph.jpg GRAPHIC 29187
11 fcsccolorlogoa03.jpg GRAPHIC 74382
  Complete submission text file 0001628280-17-011448.txt   5558744

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT fcsc-20170930.xml EX-101.INS 1096071
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fcsc-20170930.xsd EX-101.SCH 41920
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fcsc-20170930_cal.xml EX-101.CAL 60337
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fcsc-20170930_def.xml EX-101.DEF 240630
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fcsc-20170930_lab.xml EX-101.LAB 575556
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fcsc-20170930_pre.xml EX-101.PRE 361705
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31564 | Film No.: 171195418
SIC: 2834 Pharmaceutical Preparations